107 related articles for article (PubMed ID: 3518293)
1. Detection of Clostridium difficile Toxin A by immunoblotting.
Rautenberg P; Stender F; Ullmann U
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Feb; 261(1):29-42. PubMed ID: 3518293
[TBL] [Abstract][Full Text] [Related]
2. Monospecific antibodies for detection of Clostridium difficile enterotoxin.
Rautenberg P; Stender F; Ullmann U
Eur J Clin Microbiol; 1987 Feb; 6(1):62-4. PubMed ID: 3552665
[TBL] [Abstract][Full Text] [Related]
3. Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
Lyerly DM; Phelps CJ; Toth J; Wilkins TD
Infect Immun; 1986 Oct; 54(1):70-6. PubMed ID: 2428753
[TBL] [Abstract][Full Text] [Related]
4. [Preparation and characterization of monoclonal antibody against Clostridium difficile toxin A].
Fu SW; Zhou DY; Lai ZS; Xue J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):376-8. PubMed ID: 15193243
[TBL] [Abstract][Full Text] [Related]
5. Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection.
Zhang Z; Chen X; Hernandez LD; Lipari P; Flattery A; Chen SC; Kramer S; Polishook JD; Racine F; Cape H; Kelly CP; Therien AG
Infect Immun; 2015 Jan; 83(1):405-16. PubMed ID: 25385797
[TBL] [Abstract][Full Text] [Related]
6. Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
Torres JF; Monath TP
J Med Microbiol; 1996 Jun; 44(6):464-74. PubMed ID: 8636964
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin).
Martinez RD; Wilkins TD
Infect Immun; 1988 May; 56(5):1215-21. PubMed ID: 3128481
[TBL] [Abstract][Full Text] [Related]
8. Sensitive assays enable detection of serum IgG antibodies against Clostridium difficile toxin A and toxin B in healthy subjects and patients with Clostridium difficile infection.
Zhao X; Bender F; Shukla R; Kang JJ; Caro-Aguilar I; Laterza OF
Bioanalysis; 2016 Apr; 8(7):611-23. PubMed ID: 26964649
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a commercially available latex immunoagglutination test kit for detection of Clostridium difficile D-1 toxin.
Kamiya S; Nakamura S; Yamakawa K; Nishida S
Microbiol Immunol; 1986; 30(2):177-81. PubMed ID: 3086678
[No Abstract] [Full Text] [Related]
10. A non-haemagglutinating form of Clostridium difficile toxin A.
Kamiya S; Borriello SP
J Med Microbiol; 1992 Mar; 36(3):190-7. PubMed ID: 1548692
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens.
Vanpoucke H; De Baere T; Claeys G; Vaneechoutte M; Verschraegen G
Clin Microbiol Infect; 2001 Feb; 7(2):55-64. PubMed ID: 11298143
[TBL] [Abstract][Full Text] [Related]
12. Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system.
Deng XK; Nesbit LA; Morrow KJ
Clin Diagn Lab Immunol; 2003 Jul; 10(4):587-95. PubMed ID: 12853390
[TBL] [Abstract][Full Text] [Related]
13. [Immunocytochemistry of Clostridium novyi antigens. Electron microscopic research].
Vaĭsman ISh; Postanogova GV; Chemurzieva NV
Zh Mikrobiol Epidemiol Immunobiol; 1986 May; (5):49-52. PubMed ID: 3524081
[TBL] [Abstract][Full Text] [Related]
14. Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein.
Borriello SP; Barclay FE; Reed PJ; Welch AR; Brown JD; Burdon DW
J Clin Pathol; 1987 May; 40(5):573-80. PubMed ID: 3108333
[TBL] [Abstract][Full Text] [Related]
15. Enzyme-linked immunosorbent assay for Clostridium difficile toxin A.
Lyerly DM; Sullivan NM; Wilkins TD
J Clin Microbiol; 1983 Jan; 17(1):72-8. PubMed ID: 6338036
[TBL] [Abstract][Full Text] [Related]
16. Development of an ELISA kit using monoclonal antibody to Clostridium difficile toxin A.
Fu SW; Zhang YL; Zhou DY
World J Gastroenterol; 2004 Sep; 10(18):2747-9. PubMed ID: 15309733
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile.
Martinez RD; Wilkins TD
J Med Microbiol; 1992 Jan; 36(1):30-6. PubMed ID: 1370542
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Clostridium difficile toxin A and B by 1,2-cyclohexanedione modification of an arginine residue.
Balfanz J; Rautenberg P
Biochem Biophys Res Commun; 1989 Dec; 165(3):1364-70. PubMed ID: 2610698
[TBL] [Abstract][Full Text] [Related]
19. Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.
Corthier G; Muller MC; Wilkins TD; Lyerly D; L'Haridon R
Infect Immun; 1991 Mar; 59(3):1192-5. PubMed ID: 1900059
[TBL] [Abstract][Full Text] [Related]
20. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
Kyne L; Warny M; Qamar A; Kelly CP
N Engl J Med; 2000 Feb; 342(6):390-7. PubMed ID: 10666429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
